Ciltacabtagene car-pos t
Full descriptor
Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Details
- Code
- Q2056
- Short descriptor
- Ciltacabtagene car-pos t
- Code set
- HCPCS Level II
- Release
- July 2026
- Status
- Active
- Added
- Oct 1 2022
Nearby codes
Code sets are published in blocks, so neighbours are usually related.
Idecabtagene vicleucel car
Afamitresgene autoleucel
Lisocabtagene mara car pos t
Obecbtge autol up to 400 mil
Brexucabtagene car pos t
Home ivig, services/supplies
Doxorubicin inj 10mg
Imported lipodox inj
Sources
- CMS HCPCS Level II — July 2026, public domain
Reference information only. Not billing advice. Verify against the payer before you file.